Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - Merck & Co., Inc. (0000310158) (Filer)
Merck & Co., Inc. filed a Form 8-K reporting the departure and appointment of certain officers and directors, along with related compensatory arrangements for those officers, under Item 5.02.
- First Lady Melania Trump Launches 2027 Presidential SI Challenge and Establishes First Lady Seal of SI Readiness
First Lady Melania Trump announced the 2027 Presidential Super Intelligence Challenge and introduced a First Lady Seal of AI Readiness, inviting K-12 students, educators and schools nationwide to take part.
- 8-K - Bridgecrest Lending Auto Securitization Trust 2026-4 (0002151184) (Filer)
Bridgecrest Lending Auto Securitization Trust 2026-4 filed an 8-K with the SEC on October 13, 2026 (AccNo 0001104659-26-115379), containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Bridgecrest Auto Funding LLC (0001974820) (Filer)
Bridgecrest Auto Funding LLC filed a Form 8-K with the SEC on October 13, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001104659-26-115379.
- 8-K - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)
Wheeler Real Estate Investment Trust, Inc. filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Bridgecrest Lending Auto Securitization Trust 2026-4 (0002151184) (Filer)
Bridgecrest Lending Auto Securitization Trust 2026-4 filed a Form 8-K on October 13, 2026, reporting a material definitive agreement, other events, and accompanying financial statements and exhibits.
- 8-K - Bridgecrest Auto Funding LLC (0001974820) (Filer)
Bridgecrest Auto Funding LLC filed a Form 8-K on October 13, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.
- 8-K - Federal Home Loan Bank of San Francisco (0001316944) (Filer)
On October 13, 2026, Federal Home Loan Bank of San Francisco filed a Form 8-K reporting the creation of a direct financial obligation or an off-balance-sheet arrangement.
- 8-K - LAKELAND FINANCIAL CORP (0000721994) (Filer)
Lakeland Financial Corp filed a Form 8-K on October 13, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Federal Home Loan Bank of Atlanta (0001331465) (Filer)
On October 13, 2026, Federal Home Loan Bank of Atlanta filed a Form 8-K reporting the creation of a direct financial obligation and/or an off-balance-sheet arrangement.
- Minutes of the Money Market Committee meeting – September 2026
The Bank of England released minutes from its Money Markets Committee meeting held in September 2026, detailing discussions on the UK unsecured deposits and funding market, securities lending, and repo markets.
- 8-K/A - Boxlight Corp (0001624512) (Filer)
Boxlight Corp filed a Form 8-K/A on October 13, 2026, reporting entry into a material definitive agreement, material modifications to security holders’ rights, and the inclusion of financial statements and related exhibits.
- 8-K - Victory Capital Holdings, Inc. (0001570827) (Filer)
Victory Capital Holdings, Inc. filed a Form 8-K on October 13, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - T. Rowe Price OHA Select Private Credit Fund (0001901164) (Filer)
On October 13, 2026, T. Rowe Price OHA Select Private Credit Fund filed a Form 8-K (Accession No. 0001140361-26-039391) reporting that matters have been submitted to its security holders for a vote.
- 8-K - CITIGROUP INC (0000831001) (Filer)
Citigroup Inc. filed an 8-K with the SEC on October 13, 2026, including Item 2.02 covering its results of operations and financial condition, and Item 9.01 presenting its financial statements and related exhibits.
- 8-K - PROCTER & GAMBLE Co (0000080424) (Filer)
Procter & Gamble Co. filed a Form 8-K on October 13, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - AVALON HOLDINGS CORP (0001061069) (Filer)
Avalon Holdings Corp filed a Form 8-K with the SEC on October 13, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits (Accession No. 0001437749-26-032511, 1 MB).
- 8-K - Federal Home Loan Bank of Pittsburgh (0001330399) (Filer)
The Federal Home Loan Bank of Pittsburgh filed an 8-K on October 13, 2026, disclosing the creation of a direct financial obligation or off-balance-sheet arrangement and including its financial statements and related exhibits.
- 8-K - Cavitation Technologies, Inc. (0001376793) (Filer)
Cavitation Technologies, Inc. filed an 8-K reporting entry into a material definitive agreement, termination of a material definitive agreement, other events, and accompanying financial statements and exhibits.
- 8-K - JPMORGAN CHASE & CO (0000019617) (Filer)
JPMorgan Chase & Co. filed a Form 8-K on October 13, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - Federal Home Loan Bank of Dallas (0001331757) (Filer)
In a Form 8-K filed on October 13, 2026, Federal Home Loan Bank of Dallas disclosed under Item 2.03 the creation of a direct financial obligation and/or an off-balance-sheet arrangement.
- 8-K - Crexendo, Inc. (0001075736) (Filer)
Crexendo, Inc. filed a Form 8-K on October 13, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - Alaunos Therapeutics, Inc. (0001107421) (Filer)
Alaunos Therapeutics, Inc. filed an 8-K reporting a material definitive agreement, completion of an acquisition, unregistered equity sales, changes to directors and officers with related compensation, amendments to its articles and bylaws, a Regulation FD disclosure, and accompanying financial statements.
- 8-K - SkyAI, Inc. (0001737995) (Filer)
SkyAI, Inc. filed a Form 8-K with the SEC on October 13, 2026, reporting under Item 8.01 (Other Events) and including Item 9.01 (Financial Statements and Exhibits).
- 8-K - SSR MINING INC. (0000921638) (Filer)
SSR Mining Inc. filed a Form 8-K on October 13, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - SS Innovations International, Inc. (0001676163) (Filer)
SS Innovations International, Inc. filed a Form 8-K on October 13, 2026, reporting other events under Item 8.01 and providing financial statements and exhibits under Item 9.01.
- 8-K - bioAffinity Technologies, Inc. (0001712762) (Filer)
bioAffinity Technologies, Inc. filed a Form 8-K on October 13, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Dream Finders Homes, Inc. (0001825088) (Filer)
Dream Finders Homes, Inc. filed a Form 8-K on October 13, 2026 disclosing the creation of a direct financial obligation and/or an off-balance-sheet arrangement as required under Item 2.03 of the filing.
- 8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
Apimeds Pharmaceuticals US, Inc. filed a Form 8-K on October 13, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001213900-26-108780.
- 8-K - Bluejay Diagnostics, Inc. (0001704287) (Filer)
Bluejay Diagnostics, Inc. filed a Form 8-K with the SEC on October 13, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).